[go: up one dir, main page]

IL84595A0 - Cell lines and monoclonal antibodies produced thereby - Google Patents

Cell lines and monoclonal antibodies produced thereby

Info

Publication number
IL84595A0
IL84595A0 IL84595A IL8459587A IL84595A0 IL 84595 A0 IL84595 A0 IL 84595A0 IL 84595 A IL84595 A IL 84595A IL 8459587 A IL8459587 A IL 8459587A IL 84595 A0 IL84595 A0 IL 84595A0
Authority
IL
Israel
Prior art keywords
human
reactivity
monoclonal antibodies
cells
cell lines
Prior art date
Application number
IL84595A
Other languages
English (en)
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of IL84595A0 publication Critical patent/IL84595A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL84595A 1986-12-08 1987-11-25 Cell lines and monoclonal antibodies produced thereby IL84595A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93886486A 1986-12-08 1986-12-08
US07/070,202 US4931395A (en) 1986-12-08 1987-07-06 Monoclonal antibody specific to neutrophils

Publications (1)

Publication Number Publication Date
IL84595A0 true IL84595A0 (en) 1988-04-29

Family

ID=26750894

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84595A IL84595A0 (en) 1986-12-08 1987-11-25 Cell lines and monoclonal antibodies produced thereby

Country Status (14)

Country Link
US (1) US4931395A (es)
EP (1) EP0338003B1 (es)
JP (2) JP2554153B2 (es)
KR (1) KR960013131B1 (es)
CN (1) CN1024285C (es)
AT (1) ATE88751T1 (es)
AU (1) AU611407B2 (es)
CA (1) CA1283066C (es)
DE (1) DE3785673T2 (es)
DK (1) DK440988A (es)
IL (1) IL84595A0 (es)
MX (1) MX9203237A (es)
NO (1) NO174855C (es)
WO (1) WO1988004320A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618212B2 (en) * 1987-06-30 1991-12-12 Coulter International Corporation Monoclonal antibody specific to a common determinant site of neutrophils and eosinophils
IE67038B1 (en) * 1988-12-22 1996-02-21 Patrick Joseph Joyce Immunodiagnostic assays for use in the detection and determination of mastitis
US5348859A (en) * 1990-11-23 1994-09-20 Coulter Corporation Method and apparatus for obtaining an absolute white blood cell subset count and white blood cell multipart differential
US5814468A (en) * 1996-03-27 1998-09-29 Coulter International Corp. Methods of enumerating receptor molecules for specific binding partners on formed bodies and in solution
US6696243B2 (en) 2001-01-23 2004-02-24 Coulter International Corp. Method for the analysis of soluble analytes
US6811777B2 (en) 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
US7608258B2 (en) * 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
US7678780B2 (en) * 2003-12-29 2010-03-16 Allan Mishra Method of treating cancer using platelet releasate
WO2005065419A2 (en) * 2003-12-29 2005-07-21 Am Biosolutions Method of culturing cells
WO2005065269A2 (en) * 2003-12-29 2005-07-21 Am Biosolutions Compositions and method for decreasing the appearance of skin wrinkles
US7462268B2 (en) * 2004-08-20 2008-12-09 Allan Mishra Particle/cell separation device and compositions
WO2010042658A1 (en) 2008-10-07 2010-04-15 Bioparadox, Llc Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
US20140356893A1 (en) 2013-06-04 2014-12-04 Allan Mishra Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618212B2 (en) * 1987-06-30 1991-12-12 Coulter International Corporation Monoclonal antibody specific to a common determinant site of neutrophils and eosinophils

Also Published As

Publication number Publication date
DK440988D0 (da) 1988-08-05
EP0338003A4 (en) 1990-01-26
NO883495L (no) 1988-08-05
NO883495D0 (no) 1988-08-05
JP2554153B2 (ja) 1996-11-13
CN87107275A (zh) 1988-08-17
JPH02501029A (ja) 1990-04-12
NO174855C (no) 1994-07-20
CN1024285C (zh) 1994-04-20
ATE88751T1 (de) 1993-05-15
WO1988004320A1 (en) 1988-06-16
US4931395A (en) 1990-06-05
JPH08275775A (ja) 1996-10-22
AU611407B2 (en) 1991-06-13
EP0338003B1 (en) 1993-04-28
DE3785673D1 (de) 1993-06-03
MX9203237A (es) 1992-07-01
CA1283066C (en) 1991-04-16
DK440988A (da) 1988-08-05
AU1046088A (en) 1988-06-30
EP0338003A1 (en) 1989-10-25
JP2667140B2 (ja) 1997-10-27
KR960013131B1 (ko) 1996-09-30
NO174855B (no) 1994-04-11
KR890700161A (ko) 1989-03-10
DE3785673T2 (de) 1993-08-19

Similar Documents

Publication Publication Date Title
IL84595A0 (en) Cell lines and monoclonal antibodies produced thereby
EP0280209A3 (en) Monoclonal antibodies against melanoma-associated antigens, hybrid cell lines producing these antibodies, and use therefor
KR880006357A (ko) 인터류킨-i에 대한 항체
DE3852054D1 (de) Monoklonale Antikörper gegen Glycolipid-Antigene und ihre Verwendung.
AU529210B3 (en) Monoclonal antibody in occult blood diagnosis
DE3586440D1 (de) Zur diagnose von menschlichem magen- oder brustkrebs zu verwendender monoklonaler antikoerper.
EP0385601A3 (en) Cross-linked antibodies and processes for their preparation.
ATE13692T1 (de) Hybridzellinie zur herstellung komplementfixierender monoklonaler antikoerper gegen menschliche suppressor-t-zellen; antikoerper und verfahren zu seiner herstellung; diagnostische und therapeutische verwendungen und diesen antikoerper enthaltende pharmazeutische zusammensetzungen.
KR100215606B1 (en) Toxoplasma gondii antigens, the preparation thereof and the diagnostic agent containing them
IL61863A (en) Monoclonal antibody to a human monocyte antigen,its production and diagnostic and pharmaceutical compositions contaiing it
DK0687295T3 (da) Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof
ZA875551B (en) Monoclonal antibodies and their production and use
EP0232871A3 (en) Human monoclonal antibody, hybridoma producing the same and its use
GB2182949A (en) Monoclonal antibodies and antigens for human non-small cell lung carcinomas
EP0204522A3 (en) Monoclonal antibody panel for histocompatibility typing
DE3278505D1 (en) Hybridoma antibody which inhibits interleukin-2 activity and its use as a reagent for interleukin-2 detection, the production of said antibody, a process for producing hybrid anti-interleukin-2 antibody producing cells, and such cells
ZA904229B (en) Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment
ES2010761A6 (es) Un procedimiento para obtener una linea celular hibrida productora de un anticuerpo monoclonal especifico de sitio determinante comun de neutrofilos y eosinofilos.
JPS6445398A (en) Antithrombin-binding substance monoclonal antibody, hybridoma producing said antibody and method for purifying and measuring thrombin-binding substance utilizing said monoclonal antibody
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
ES2008956A6 (es) Un procedimiebto para obtener una linea de celulas hibridas capaces deproducir anticuerpos monoclonales singularmente especificos de los neutrofilos humanos.
DE3579808D1 (de) Anti-urokinase monoklonaler antikoerper, seine herstellung und verwendung.
JPS6427491A (en) Monoclonal antibody
JPS6490198A (en) Monoclonal antibody, its production and reagent consisting thereof for detecting virus
EP0311438A3 (en) Monoclonal antibody to activated lymphocytes and cancer cells